Transport Platform Synthesis for Drug Development
- Авторлар: Stukalov Y.V.1, Grigor’eva E.Y.1, Kulakov V.N.2, Baryshnikov A.Y.1
-
Мекемелер:
- N. N. Blokhin Russian Cancer Research Center
- A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
- Шығарылым: Том 51, № 6 (2017)
- Беттер: 480-481
- Бөлім: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244661
- DOI: https://doi.org/10.1007/s11094-017-1637-9
- ID: 244661
Дәйексөз келтіру
Аннотация
Asynthetic scheme for a transport platform for the creation of new diagnostic and therapeutic antitumor drugs that was based on a dendrimer with a core of pentaerythritol tetraglycidyl ether (TGEPE) and dendra with diallylamine was developed. The transport platform was promising for designing targeted antitumor agents for magnetic resonance tomography and nuclear medicine.
Негізгі сөздер
Авторлар туралы
Yu. Stukalov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Ресей, 24 Kashirskoe Shosse, Moscow, 115478
E. Grigor’eva
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Ресей, 24 Kashirskoe Shosse, Moscow, 115478
V. Kulakov
A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
Email: chem@folium.ru
Ресей, 46 Zhivopisnaya St, Moscow, 123182
A. Baryshnikov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Ресей, 24 Kashirskoe Shosse, Moscow, 115478
Қосымша файлдар
